Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Biopharmaceutical company ImClone Systems has appointed Kenneth Zuerblis as senior vice president and CFO, effective March 31, 2008.
Subscribe to our email newsletter
Mr Zuerblis brings to ImClone more than 25 years of financial and operational management experience. Mr Zuerblis is best known within the biotechnology industry as a former CFO of Enzon Pharmaceuticals.
During his 11-year tenure as Enzon’s CFO, the company successfully transitioned from a small, royalty-based specialty pharmaceutical organization into a fully integrated biopharmaceutical company with significant revenues driven by five marketed products and substantial capabilities in research, development, manufacturing, sales and marketing.
John Johnson, CEO of ImClone, said: “We believe Ken will contribute substantially to ImClone’s efforts in becoming a fully-integrated global leader in cancer therapies as we continue to aggressively pursue initiatives to maximize our Erbitux franchise and further advance our robust pipeline of novel antibodies.”